Current Month 2009
Article Features
  Breast Cancer Patients with High Risk Gene Diagnosed Six Years Earlier than Generation Before
Emotional Toll of Breast Cancer on Well-Educated Women and Those Who Live Alone
Gene Blamed for Immunological Disorders Shown to Protect Against Breast Cancer Development
Hormone Mix Could Cut Breast Cancer Risk and Treat Symptoms of Menopause
Increased Levels of Muellerian-Inhibiting Substance Could Mean Greater Breast Cancer Risk
Study Finds No Relationship Between Pathological Complete Response Rate and Race in Women with Breast Cancer
Study Shows How Normal Cells Influence Tumor Growth
Surviving Breast Cancer Low-Income Females Worst Hit by Breast Cancer

Surgeons' Consensus: Needle Biopsy is Gold Standard for Breast Cancer Diagnosis

A special report published in the October issue of the Journal of the American College of Surgeons indicates that an alarming 35% of initial diagnostic breast biopsies in the United States are still being done using unnecessary open surgical techniques. This in spite of the fact that it costs as much as three times more than the much less invasive and equally accurate needle biopsy technique.

A panel of leading breast disease specialists recently convened at the International Consensus Conference on Image Detected Breast Cancer III and unanimously agreed that percutaneous needle biopsy represents "best practice" and should be the "gold standard" for initial diagnosis of breast abnormalities. The recommendations were reached after building clinical evidence since the preceeding Consensus Conferences in 2001 and 2005, yet little progress is being made in reducing the number of open surgical biopsies being performed nationwide.

Read More of the Main Article

Visit the Ezine

Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon